Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study.

In Southern U.S. states with high HIV incidence and low HIV Pre-Exposure Prophylaxis (PrEP) uptake, enhanced efforts to increase interest in and willingness to use PrEP are needed.

Predicting Long-Term Mortality Using American College of Cardiology (ACC)/American Heart Association (AHA) Pooled Cardiovascular Risk Cohort Equations: Implications for Lipid-Lowering Therapy.

Introduction: Primary prevention statin therapy is initiated based on the 10-year ASCVD risk estimated by the pooled cohort equations (PCEs), with treatment effectiveness monitored through low-density lipoprotein cholesterol levels. It remains uncertain whether ASCVD risk accurately predicts the mortality impact of lipid-lowering therapy. This study aims to assess the predictive performance of the PCE for mortality with and without lipid-lowering therapy and the mortality impact of lipid-lowering therapy with similar ASCVD risk.